BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coelho JE, Alves P, Canas PM, Valadas JS, Shmidt T, Batalha VL, Ferreira DG, Ribeiro JA, Bader M, Cunha RA, do Couto FS, Lopes LV. Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety. Front Psychiatry 2014;5:67. [PMID: 24982640 DOI: 10.3389/fpsyt.2014.00067] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Martí Navia A, Dal Ben D, Lambertucci C, Spinaci A, Volpini R, Marques-Morgado I, Coelho JE, Lopes LV, Marucci G, Buccioni M. Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists. Cells 2020;9:E1739. [PMID: 32708189 DOI: 10.3390/cells9071739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Chiodi V, Ferrante A, Ferraro L, Potenza RL, Armida M, Beggiato S, Pèzzola A, Bader M, Fuxe K, Popoli P, Domenici MR. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. J Neurochem 2016;136:907-17. [PMID: 26526685 DOI: 10.1111/jnc.13421] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
3 Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szegö ÉM, Marques-Morgado I, Vaz SH, Rhee JS, Schmitz M, Zerr I, Lopes LV, Outeiro TF. α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci 2017;20:1569-79. [PMID: 28945221 DOI: 10.1038/nn.4648] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 24.0] [Reference Citation Analysis]
4 Tescarollo FC, Rombo DM, DeLiberto LK, Fedele DE, Alharfoush E, Tomé ÂR, Cunha RA, Sebastião AM, Boison D. Role of Adenosine in Epilepsy and Seizures. J Caffeine Adenosine Res 2020;10:45-60. [PMID: 32566903 DOI: 10.1089/caff.2019.0022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sikka P, Behl T, Chandel P, Sehgal A, Singh S, Makeen HA, Albratty M, Alhazmi HA, Meraya AM. Scrutinizing the Therapeutic Promise of Purinergic Receptors Targeting Depression. Neurotox Res 2022. [PMID: 35930172 DOI: 10.1007/s12640-022-00550-2] [Reference Citation Analysis]
6 Mouro FM, Ribeiro JA, Sebastião AM, Dawson N. Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity. J Neurochem 2018;147:71-83. [PMID: 29989183 DOI: 10.1111/jnc.14549] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
7 Cheffer A, Castillo ARG, Corrêa-Velloso J, Gonçalves MCB, Naaldijk Y, Nascimento IC, Burnstock G, Ulrich H. Purinergic system in psychiatric diseases. Mol Psychiatry 2018;23:94-106. [PMID: 28948971 DOI: 10.1038/mp.2017.188] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 14.4] [Reference Citation Analysis]
8 Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu SG, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 2021;6:162. [PMID: 33907179 DOI: 10.1038/s41392-021-00553-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Chen JF, Cunha RA. The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease. Purinergic Signal 2020;16:167-74. [PMID: 32236790 DOI: 10.1007/s11302-020-09694-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 20.5] [Reference Citation Analysis]
10 Poleszak E, Szopa A, Bogatko K, Wyska E, Wośko S, Świąder K, Doboszewska U, Wlaź A, Wróbel A, Wlaź P, Serefko A. Antidepressant-Like Activity of Typical Antidepressant Drugs in the Forced Swim Test and Tail Suspension Test in Mice Is Augmented by DMPX, an Adenosine A2A Receptor Antagonist. Neurotox Res 2019;35:344-52. [PMID: 30267268 DOI: 10.1007/s12640-018-9959-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
11 Almeida RF, Comasseto DD, Ramos DB, Hansel G, Zimmer ER, Loureiro SO, Ganzella M, Souza DO. Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems. Mol Neurobiol 2017;54:423-36. [PMID: 26742520 DOI: 10.1007/s12035-015-9660-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
12 Miao J, Liu L, Yan C, Zhu X, Fan M, Yu P, Ji K, Huang Y, Wang Y, Zhu G. Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population. Neuropsychiatr Dis Treat 2019;15:2451-8. [PMID: 31695381 DOI: 10.2147/NDT.S205014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 da Silva RB, Siebel AM, Bonan CD. The role of purinergic and dopaminergic systems on MK-801-induced antidepressant effects in zebrafish. Pharmacology Biochemistry and Behavior 2015;139:149-57. [DOI: 10.1016/j.pbb.2015.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Ershadi ASB, Amini-Khoei H, Hosseini MJ, Dehpour AR. SAHA Improves Depressive Symptoms, Cognitive Impairment and Oxidative Stress: Rise of a New Antidepressant Class. Neurochem Res 2021;46:1252-63. [PMID: 33576938 DOI: 10.1007/s11064-021-03263-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang ZH, Xu YW, Peng Y, Chen X, Li P, Zhou YG. Expression of a short antibody heavy chain peptide effectively antagonizes adenosine 2A receptor in vitro and in vivo. Expert Opin Ther Targets 2020;24:707-17. [PMID: 32308059 DOI: 10.1080/14728222.2020.1758667] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Bruijnzeel AW, Knight P, Panunzio S, Xue S, Bruner MM, Wall SC, Pompilus M, Febo M, Setlow B. Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood. Psychopharmacology (Berl) 2019;236:2773-84. [PMID: 31044291 DOI: 10.1007/s00213-019-05255-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
17 Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K, Faivre E, Costa-Pereira S, Darrigues J, de Almeida AA, Buée L, Dunot J, Marie H, Pousinha PA, Blum D, Silva-Santos B, Lopes LV, Ribot JC. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease. Cell Rep 2021;36:109574. [PMID: 34469732 DOI: 10.1016/j.celrep.2021.109574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Calker D, Biber K, Domschke K, Serchov T. The role of adenosine receptors in mood and anxiety disorders. J Neurochem 2019;151:11-27. [DOI: 10.1111/jnc.14841] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
19 Rial D, Lemos C, Pinheiro H, Duarte JM, Gonçalves FQ, Real JI, Prediger RD, Gonçalves N, Gomes CA, Canas PM, Agostinho P, Cunha RA. Depression as a Glial-Based Synaptic Dysfunction. Front Cell Neurosci 2015;9:521. [PMID: 26834566 DOI: 10.3389/fncel.2015.00521] [Cited by in Crossref: 52] [Cited by in F6Publishing: 75] [Article Influence: 8.7] [Reference Citation Analysis]
20 Govindula A, Pai A, Baghel S, Mudgal J. Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update. Eur J Pharmacol 2021;908:174364. [PMID: 34297967 DOI: 10.1016/j.ejphar.2021.174364] [Reference Citation Analysis]
21 Domenici MR, Ferrante A, Martire A, Chiodi V, Pepponi R, Tebano MT, Popoli P. Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders. Pharmacological Research 2019;147:104338. [DOI: 10.1016/j.phrs.2019.104338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
22 Gonçalves MCB, Glaser T, Oliveira SLBD, Ulrich H. Adenosinergic-Dopaminergic Signaling in Mood Disorders: A Mini-Review. Journal of Caffeine and Adenosine Research 2020;10:94-103. [DOI: 10.1089/caff.2020.0009] [Reference Citation Analysis]
23 Frick A, Persson J, Bodén R. Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation. J Psychopharmacol 2021;35:1536-41. [PMID: 34872405 DOI: 10.1177/02698811211058975] [Reference Citation Analysis]
24 Towers AE, Oelschlager ML, Lorenz M, Gainey SJ, McCusker RH, Krauklis SA, Freund GG. Handling stress impairs learning through a mechanism involving caspase-1 activation and adenosine signaling. Brain Behav Immun 2019;80:763-76. [PMID: 31108171 DOI: 10.1016/j.bbi.2019.05.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Brkic Z, Milosavljevic M, Glavonic E, Adzic M. Mitochondrial signaling in inflammation-induced depressive behavior in female and male rats: The role of glucocorticoid receptor. Brain Res Bull 2019;150:317-27. [PMID: 31251961 DOI: 10.1016/j.brainresbull.2019.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Mouro FM, Köfalvi A, André LA, Baqi Y, Müller CE, Ribeiro JA, Sebastião AM. Memory deficits induced by chronic cannabinoid exposure are prevented by adenosine A2AR receptor antagonism. Neuropharmacology 2019;155:10-21. [DOI: 10.1016/j.neuropharm.2019.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
27 Al-attraqchi OH, Attimarad M, Venugopala KN, Nair A, Al-attraqchi NH. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. CPD 2019;25:2716-40. [DOI: 10.2174/1381612825666190716113444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
28 Liu Y, Wang J, Wang W, Zhang H, Zhang X, Han C. The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis. Evid Based Complement Alternat Med 2015;2015:575063. [PMID: 25960753 DOI: 10.1155/2015/575063] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
29 Machado DG, Lara MVS, Dobler PB, Almeida RF, Porciúncula LO. Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020;98:109776. [DOI: 10.1016/j.pnpbp.2019.109776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Caetano L, Pinheiro H, Patrício P, Mateus-Pinheiro A, Alves ND, Coimbra B, Baptista FI, Henriques SN, Cunha C, Santos AR, Ferreira SG, Sardinha VM, Oliveira JF, Ambrósio AF, Sousa N, Cunha RA, Rodrigues AJ, Pinto L, Gomes CA. Adenosine A2A receptor regulation of microglia morphological remodeling-gender bias in physiology and in a model of chronic anxiety. Mol Psychiatry 2017;22:1035-43. [PMID: 27725661 DOI: 10.1038/mp.2016.173] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
31 Gomes JI, Farinha-Ferreira M, Rei N, Gonçalves-Ribeiro J, Ribeiro JA, Sebastião AM, Vaz SH. Of adenosine and the blues: The adenosinergic system in the pathophysiology and treatment of major depressive disorder. Pharmacol Res 2021;163:105363. [PMID: 33285234 DOI: 10.1016/j.phrs.2020.105363] [Reference Citation Analysis]
32 Zimmermann FF, Altenhofen S, Kist LW, Leite CE, Bogo MR, Cognato GP, Bonan CD. Unpredictable Chronic Stress Alters Adenosine Metabolism in Zebrafish Brain. Mol Neurobiol 2016;53:2518-28. [PMID: 26081145 DOI: 10.1007/s12035-015-9270-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
33 Risal S, Manti M, Lu H, Fornes R, Larsson H, Benrick A, Deng Q, Cesta CE, Rosenqvist MA, Stener-Victorin E. Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders. Transl Psychiatry 2021;11:45. [PMID: 33441551 DOI: 10.1038/s41398-020-01183-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
34 Reis SL, Silva HB, Almeida M, Cunha RA, Simões AP, Canas PM. Adenosine A 1 and A 2A receptors differently control synaptic plasticity in the mouse dorsal and ventral hippocampus. J Neurochem 2019;151:227-37. [DOI: 10.1111/jnc.14816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Moreira-de-Sá A, Lourenço VS, Canas PM, Cunha RA. Adenosine A2A Receptors as Biomarkers of Brain Diseases. Front Neurosci 2021;15:702581. [PMID: 34335174 DOI: 10.3389/fnins.2021.702581] [Reference Citation Analysis]
36 Bibi S, Wang YB, Tang DX, Kamal MA, Yu H. Prospects for Discovering the Secondary Metabolites of Cordyceps Sensu Lato by the Integrated Strategy. Med Chem 2021;17:97-120. [PMID: 31880251 DOI: 10.2174/1573406416666191227120425] [Reference Citation Analysis]
37 Domenici MR, Chiodi V, Averna M, Armida M, Pèzzola A, Pepponi R, Ferrante A, Bader M, Fuxe K, Popoli P. Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease. Purinergic Signal 2018;14:235-43. [PMID: 29770921 DOI: 10.1007/s11302-018-9609-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Temido-Ferreira M, Ferreira DG, Batalha VL, Marques-Morgado I, Coelho JE, Pereira P, Gomes R, Pinto A, Carvalho S, Canas PM, Cuvelier L, Buée-Scherrer V, Faivre E, Baqi Y, Müller CE, Pimentel J, Schiffmann SN, Buée L, Bader M, Outeiro TF, Blum D, Cunha RA, Marie H, Pousinha PA, Lopes LV. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Mol Psychiatry 2020;25:1876-900. [PMID: 29950682 DOI: 10.1038/s41380-018-0110-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 19.8] [Reference Citation Analysis]
39 Bartoli F, Burnstock G, Crocamo C, Carrà G. Purinergic Signaling and Related Biomarkers in Depression. Brain Sci 2020;10:E160. [PMID: 32178222 DOI: 10.3390/brainsci10030160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
40 Leffa DT, Pandolfo P, Gonçalves N, Machado NJ, de Souza CM, Real JI, Silva AC, Silva HB, Köfalvi A, Cunha RA, Ferreira SG. Adenosine A2A Receptors in the Rat Prelimbic Medial Prefrontal Cortex Control Delay-Based Cost-Benefit Decision Making. Front Mol Neurosci 2018;11:475. [PMID: 30618621 DOI: 10.3389/fnmol.2018.00475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
41 Sragovich S, Amram N, Yeheskel A, Gozes I. VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects. Front Cell Neurosci 2019;13:589. [PMID: 31992971 DOI: 10.3389/fncel.2019.00589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Sinen O, Bülbül M, Derin N, Ozkan A, Akcay G, Aslan MA, Agar A. The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson’s disease. International Journal of Neuroscience 2021;131:765-74. [DOI: 10.1080/00207454.2020.1754213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
43 Fried NT, Elliott MB, Oshinsky ML. The Role of Adenosine Signaling in Headache: A Review. Brain Sci 2017;7:E30. [PMID: 28335379 DOI: 10.3390/brainsci7030030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
44 Kovács Z, D'Agostino DP, Diamond D, Kindy MS, Rogers C, Ari C. Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature. Front Psychiatry 2019;10:363. [PMID: 31178772 DOI: 10.3389/fpsyt.2019.00363] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
45 Nemutlu Samur D, Akçay G, Yıldırım S, Özkan A, Çeker T, Derin N, Tanrıöver G, Aslan M, Ağar A, Özbey G. Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation. Neuropharmacology 2022;:108977. [PMID: 35092748 DOI: 10.1016/j.neuropharm.2022.108977] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Gonçalves FM, Neis VB, Rieger DK, Lopes MW, Heinrich IA, Costa AP, Rodrigues ALS, Kaster MP, Leal RB. Signaling pathways underlying the antidepressant-like effect of inosine in mice. Purinergic Signal 2017;13:203-14. [PMID: 27966087 DOI: 10.1007/s11302-016-9551-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
47 Botton PH, Pochmann D, Rocha AS, Nunes F, Almeida AS, Marques DM, Porciúncula LO. Aged mice receiving caffeine since adulthood show distinct patterns of anxiety-related behavior. Physiol Behav 2017;170:47-53. [PMID: 27890589 DOI: 10.1016/j.physbeh.2016.11.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
48 Lopes JP, Morató X, Souza C, Pinhal C, Machado NJ, Canas PM, Silva HB, Stagljar I, Gandía J, Fernández-Dueñas V, Luján R, Cunha RA, Ciruela F. The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system. J Neurochem 2015;134:135-46. [PMID: 25824528 DOI: 10.1111/jnc.13109] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
49 Szopa A, Socała K, Serefko A, Doboszewska U, Wróbel A, Poleszak E, Wlaź P. Purinergic transmission in depressive disorders. Pharmacol Ther 2021;224:107821. [PMID: 33607148 DOI: 10.1016/j.pharmthera.2021.107821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Dias L, Lopes CR, Gonçalves FQ, Nunes A, Pochmann D, Machado NJ, Tomé AR, Agostinho P, Cunha RA. Crosstalk Between ATP-P2X7 and Adenosine A2A Receptors Controlling Neuroinflammation in Rats Subject to Repeated Restraint Stress. Front Cell Neurosci 2021;15:639322. [PMID: 33732112 DOI: 10.3389/fncel.2021.639322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
51 Pasquini S, Contri C, Merighi S, Gessi S, Borea PA, Varani K, Vincenzi F. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets. Int J Mol Sci 2022;23:1219. [PMID: 35163142 DOI: 10.3390/ijms23031219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
52 Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, Coelho JE, Marques-Morgado I, Valente CA, Omenetti S, Stockinger B, Waisman A, Manadas B, Lopes LV, Silva-Santos B, Ribot JC. Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol 2019;4:eaay5199. [PMID: 31604844 DOI: 10.1126/sciimmunol.aay5199] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 28.5] [Reference Citation Analysis]